Scarica l'app Stockscreener
10.96
0.18%
-0.02
Pre-mercato:
11.30
0.34
+3.10%
Precedente Chiudi:
$10.98
Aprire:
$11
Volume 24 ore:
240.50K
Relative Volume:
0.58
Capitalizzazione di mercato:
$452.86M
Reddito:
$313.73M
Utile/perdita netta:
$-31.39M
Rapporto P/E:
-14.43
EPS:
-0.7597
Flusso di cassa netto:
$-3.53M
1 W Prestazione:
-0.18%
1M Prestazione:
+6.30%
6M Prestazione:
-7.98%
1 anno Prestazione:
+21.51%
Intervallo 1D:
$10.92
$11.17
Intervallo di 1 settimana:
$10.51
$11.35
Portata 52W:
$8.36
$13.99
Angiodynamic Inc Stock (ANGO) Company Profile
Nome
Angiodynamic Inc
Settore
Industria
Telefono
(518) 798-1215
Indirizzo
14 PLAZA DRIVE, LATHAM
Compare ANGO vs ISRG, BDX, MDLN, ALC, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ANGO
Angiodynamic Inc
|
10.96 | 452.86M | 313.73M | -31.39M | -3.53M | -0.7597 |
ISRG
Intuitive Surgical Inc
|
451.38 | 159.86B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
144.17 | 41.01B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
45.32 | 38.32B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
74.45 | 36.29B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
207.88 | 30.15B | 5.40B | 1.49B | 1.78B | 10.12 |
Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-16 | Iniziato | Lake Street | Buy |
| 2024-04-05 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2023-09-25 | Iniziato | H.C. Wainwright | Buy |
| 2023-04-17 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-10-15 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2021-08-20 | Iniziato | Oppenheimer | Perform |
| 2020-11-25 | Aggiornamento | Raymond James | Mkt Perform → Strong Buy |
| 2020-04-08 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-01 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2018-04-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2018-01-05 | Downgrade | Craig Hallum | Buy → Hold |
| 2017-04-07 | Reiterato | Cantor Fitzgerald | Overweight |
| 2017-03-30 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-02-08 | Iniziato | Barclays | Equal Weight |
| 2016-11-04 | Iniziato | Cantor Fitzgerald | Buy |
| 2016-04-08 | Ripresa | Piper Jaffray | Neutral |
| 2016-01-08 | Reiterato | Canaccord Genuity | Buy |
| 2015-11-10 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-07-24 | Iniziato | KeyBanc Capital Mkts | Overweight |
| 2014-06-19 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2012-10-09 | Reiterato | Canaccord Genuity | Hold |
| 2012-06-25 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2011-07-15 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2011-07-15 | Aggiornamento | Stifel Nicolaus | Hold → Buy |
| 2011-06-14 | Downgrade | Wedbush | Neutral → Underperform |
| 2010-09-08 | Reiterato | Wedbush | Neutral |
Mostra tutto
Angiodynamic Inc Borsa (ANGO) Ultime notizie
[8-K] ANGIODYNAMICS INC Reports Material Event - Stock Titan
Fair Value Assessment | AngioDynamics Inc. posts 117.8% EPS surprise beating loss estimatesEarnings Risk - Cổng thông tin điện tử tỉnh Tây Ninh
ANGO (AngioDynamics Inc.) notches massive Q1 2026 EPS beat, but shares fall 1.24 percent on slight year over year revenue decline.Social Trade Signals - Xã Thanh Hà
AngioDynamics Growing, But With More Noise Than The Street Likes (NASDAQ:ANGO) - Seeking Alpha
AngioDynamics Inc. Q3 2026 Financial Results: Revenue, Net Loss, and Key Financial Statements Overview - Minichart
AngioDynamics (NASDAQ: ANGO) Q3 2026 revenue up 9% while net loss grows - Stock Titan
AngioDynamics, Inc. Q3 2026 Earnings Call Summary - Yahoo Finance
AngioDynamics, Inc. 2026 Q3ResultsEarnings Call Presentation (NASDAQ:ANGO) 2026-04-02 - Seeking Alpha
AngioDynamics Inc (NASDAQ:ANGO) Beats Q3 Earnings Estimates and Raises Full-Year Guidance - ChartMill
AngioDynamics Inc expected to post a loss of 11 cents a shareEarnings Preview - TradingView
AngioDynamics investors can watch Needham conference webcast April 14 - Stock Titan
Short Interest in AngioDynamics, Inc. (NASDAQ:ANGO) Decreases By 18.0% - Defense World
AngioDynamics, Inc. (NASDAQ:ANGO) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Several Insiders Invested In AngioDynamics Flagging Positive News - Yahoo Finance
Vanguard disaggregates holdings; reports 0 shares in AngioDynamics (ANGO) - Stock Titan
AngioDynamics schedules April 2 earnings call before market open - Stock Titan
Bard And AngioDynamics Resolve 11-Year Patent Dispute - Law360
AngioDynamics, Inc. $ANGO Shares Acquired by Divisadero Street Capital Management LP - MarketBeat
AngioDynamics, Inc. (NASDAQ:ANGO) Short Interest Update - MarketBeat
Veeva Systems' Stock Up After Q4 Earnings & Revenues Beat Estimates - Finviz
AngioDynamics, Inc. (NASDAQ:ANGO) Given Average Rating of “Moderate Buy” by Analysts - Defense World
Short Interest in AngioDynamics, Inc. (NASDAQ:ANGO) Decreases By 17.6% - MarketBeat
AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring a 68.70% Potential Upside Amid Healthcare Innovations - DirectorsTalk Interviews
TMDX Stock Rises as Q4 Earnings & Revenues Beat Estimates - Finviz
Hear AngioDynamics CEO Jim Clemmer live at Leerink healthcare conference - Stock Titan
Can AngioDynamics Inc. stock maintain growth trajectoryWeekly Trade Review & Fast Gain Stock Trading Tips - mfd.ru
AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring a 72.62% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
Is AngioDynamics Inc. a top pick in the sectorAnalyst Upgrade & Verified Technical Signals - mfd.ru
Bastion Asset Management Inc. Buys 304,960 Shares of AngioDynamics, Inc. $ANGO - MarketBeat
Will AngioDynamics Inc. benefit from rate cutsEarnings Risk Summary & Technical Confirmation Trade Alerts - mfd.ru
DexCom Stock Falls Despite Q4 Earnings Beat, G7 Rollout Drives Growth - Finviz
Is AngioDynamics Inc. stock influenced by commodity prices2025 Earnings Impact & Proven Capital Preservation Tips - mfd.ru
Essex Investment Management Co. LLC Increases Holdings in AngioDynamics, Inc. $ANGO - MarketBeat
Kevin Kotler discloses 5.9% AngioDynamics (ANGO) stake in 13G filing - Stock Titan
Does AngioDynamics (ANGO) Have the Potential to Rally 92.15% as Wall Street Analysts Expect? - Finviz
Here's Why You Should Add Masimo Stock to Your Portfolio Now - Finviz
AngioDynamics summit spotlights tools for clots and tough heart infections - Stock Titan
Here's Why AngioDynamics (ANGO) Is a Great 'Buy the Bottom' Stock Now - Finviz
Reasons to Add AngioDynamics Stock to Your Portfolio for Now - Finviz
Is AngioDynamics Inc. stock a smart retirement pick2025 Trading Recap & Weekly Stock Performance Updates - Mfd.ru
AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring An 81.88% Potential Upside - DirectorsTalk Interviews
Fed Watch: What is XPO Inc.’s market positionWall Street Watch & Smart Allocation Stock Tips - baoquankhu1.vn
Portfolio Update: Will AngioDynamics Inc stock benefit from M AEarnings Overview Report & Verified Chart Pattern Trade Signals - baoquankhu1.vn
RSI Check: Why is AngioDynamics Inc stock going down2025 Key Lessons & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Atherectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 - GlobeNewswire Inc.
Treasury Yields: Will AngioDynamics Inc stock recover after earnings2025 Major Catalysts & Proven Capital Preservation Methods - baoquankhu1.vn
AngioDynamics Inc Presents at J.P. Morgan Healthcare Conference - TradingView
AngioDynamics, Inc. (ANGO) Presents at 44th Annual J.P. Morgan Healthcare ConferenceSlideshow - Seeking Alpha
AngioDynamics to lay off 54 workers in Glens Falls, Queensbury - timesunion.com
3 MedTech Stocks Benefiting From Favorable Product Mix Shifts - Finviz
Down 25.0% in 4 Weeks, Here's Why You Should You Buy the Dip in AngioDynamics (ANGO) - Finviz
Angiodynamic Inc Azioni (ANGO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.78%
0.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):